ALA Diagnostics is a company founded in 2019 headquartered in Spain. Brouky records 1 investor associated with the company.
ALA Diagnostics is a biotechnological startup focused on developing diagnostic solutions for pathologies with high prevalence and unmet medical needs, particularly a Multiple Sclerosis diagnostic kit based on a patented recombinant protein biomarker.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.